2023
DOI: 10.1080/13543784.2023.2215425
|View full text |Cite
|
Sign up to set email alerts
|

Investigational anti IL-13 asthma treatments: a 2023 update

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 95 publications
0
2
0
Order By: Relevance
“…Earlier studies have established that IL-12 can exacerbate cytotoxic effects in mice with autoimmune thyroiditis by eliciting a Th1 immune response ( 36 ). IL-13, a member of the interleukin family, is largely secreted by activated Th2 cells and plays a critical role in allergic inflammation ( 37 ). It promotes M2 polarization.…”
Section: Discussionmentioning
confidence: 99%
“…Earlier studies have established that IL-12 can exacerbate cytotoxic effects in mice with autoimmune thyroiditis by eliciting a Th1 immune response ( 36 ). IL-13, a member of the interleukin family, is largely secreted by activated Th2 cells and plays a critical role in allergic inflammation ( 37 ). It promotes M2 polarization.…”
Section: Discussionmentioning
confidence: 99%
“…Th2-released cytokines interleukin-4 (IL-4), IL-10 and especially IL-13 may play a part in the induction of proteinuria ( 7 ). IL-13 is a pleiotropic type 2 cytokine involved in the pathogenesis of many allergic ( 8 ), inflammatory ( 9 ) and malignant conditions ( 10 ). In MCD patients, IL-13 may change glomerular permeability and cause proteinuria ( 7 ).…”
Section: Introductionmentioning
confidence: 99%